Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Fidia Spa ( (IT:FDA) ).
Fidia S.p.A., a Turin‑based provider of advanced numerical controls, high‑speed milling systems and CAM software, focuses on solutions for complex machining in the automotive mould and aerospace industries. The company leverages decades of expertise to deliver integrated systems that manage the full milling workflow, from programming through to finished components.
Fidia has converted two bonds held by Global Growth Holding Limited from the third tranche of its reserved convertible bond loan into 500,000 new shares at €0.04 per share. Following this transaction, the POC is fully subscribed and converted, lifting share capital by €20,000 to €10,597,761.90 and increasing the total number of shares outstanding to 41,542,927, with the new shares immediately admitted to trading on the regulated market.
The completion of this conversion phase strengthens Fidia’s equity base and simplifies its capital structure by eliminating any remaining subscribed but unconverted bonds. For stakeholders, the move signals progress in the company’s financing plan tied to the POC, while modestly diluting existing shareholders as Fidia continues to fund its strategic and operational initiatives within the competitive industrial technology sector.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in high‑performance integrated milling systems, serving primarily the automotive mould and aerospace sectors. With over 50 years of experience and around 135 employees, the group offers end‑to‑end solutions across the milling process, including numerical controls, high‑speed milling machines and CAM software for complex shapes.
Average Trading Volume: 1,160,428
Technical Sentiment Signal: Strong Sell
Current Market Cap: €1.36M
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.